Related Experiment Video
Updated: Aug 30, 2026

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast
Published on: January 26, 2017
Targeted nucleotide exchange in the CAG repeat region of the human HD gene
Hetal Parekh-Olmedo1, Eric B Kmiec
1Department of Biology, University of Delaware, Delaware Biotechnology Institute, 15 Innovation Way, Newark, DE 19711, USA.
Insights
Researchers modified the Huntington
Area of Science:
- Genetics and Molecular Biology
- Neurodegenerative Diseases
Background:
- Huntington's disease (HD) is caused by expanded CAG repeats in the HD-gene (IT15).
- The expanded polyglutamine (poly Q) region of huntingtin protein (Htt) becomes insoluble, forming inclusions and causing neuronal death.
Purpose of the Study:
- To investigate if interrupting the poly Q tract at the genetic level can prevent Htt insolubility.
- To explore a potential therapeutic strategy for Huntington's disease by modifying the HD-gene.
Main Methods:
- Utilized modified single-stranded oligonucleotides for gene modification.
- Directed a specific nucleotide exchange (A to T) in the second codon of the HD-gene.
- Introduced a leucine residue within the poly Q tract.
Main Results:
- Successfully modified the HD-gene using synthetic DNA molecules.
- Demonstrated the feasibility of directly altering the HD-gene sequence.
- Preliminary evidence supports the potential of this genetic modification approach.
Conclusions:
- Short synthetic DNA molecules can directly modify the HD-gene.
- This genetic modification strategy shows promise as a potential therapeutic approach for Huntington's disease.
Abstract:
Huntington's disease (HD) is marked by the expansion of a tract of repeated CAG codons in the HD-gene, IT15. Once expressed, the expanded poly Q region of the huntingtin protein (Htt), which is normally soluble, becomes insoluble, leading to the formation of intracellular inclusions and ultimately to neuronal degeneration. Interruption of the pure poly Q tract at the genetic level should undermine the transition from Htt solubility to Htt insolubility. Modified single-stranded oligonucleotides were used to direct the nucleotide exchange of an A residue to a T residue in the second codon of the HD-gene, resulting in the creation of a leucine residue among the poly Q tract. Consistent with results from other groups, we provide evidence that short synthetic DNA molecules can modify the HD-gene directly, preliminarily offering a potential therapeutic approach to Huntington's disease.
Related Concept Videos
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Huntington Disease l: Introduction
Gene Conversion
RNA Editing
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...

